These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29065852)

  • 1. Genetic determinants of growth hormone and GH-related phenotypes.
    Hallengren E; Almgren P; Svensson M; Gallo W; Engström G; Persson M; Melander O
    BMC Genomics; 2017 Oct; 18(1):822. PubMed ID: 29065852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Low Frequency Protein Truncating Stop-Codon Variants and Fasting Concentration of Growth Hormone.
    Hallengren E; Almgren P; Engström G; Persson M; Melander O
    PLoS One; 2015; 10(6):e0128348. PubMed ID: 26086970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke.
    Horan M; Newsway V; Yasmin ; Lewis MD; Easter TE; Rees DA; Mahto A; Millar DS; Procter AM; Scanlon MF; Wilkinson IB; Hall IP; Wheatley A; Blakey J; Bath PM; Cockcroft JR; Krawczak M; Cooper DN
    Hum Genet; 2006 Jun; 119(5):527-40. PubMed ID: 16572267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation and human longevity.
    Soerensen M
    Dan Med J; 2012 May; 59(5):B4454. PubMed ID: 22549493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common polymorphisms in the GH/IGF-1 axis contribute to growth in extremely tall subjects.
    Hendriks AE; Brown MR; Boot AM; Oostra BA; de Jong FH; Drop SL; Parks JS
    Growth Horm IGF Res; 2011 Dec; 21(6):318-24. PubMed ID: 21944866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNPs within the GH-signaling pathway are associated with the early IGF1 response to GH replacement therapy in GHD adults.
    Glad CA; Barbosa EJ; Filipsson Nyström H; Carlsson LM; Nilsson S; Nilsson AG; Svensson PA; Johannsson G
    Eur J Endocrinol; 2014 Jan; 170(1):101-7. PubMed ID: 24114431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variations at the human growth hormone receptor (GHR) gene locus are associated with idiopathic short stature.
    Dias C; Giordano M; Frechette R; Bellone S; Polychronakos C; Legault L; Deal CL; Goodyer CG
    J Cell Mol Med; 2017 Nov; 21(11):2985-2999. PubMed ID: 28557176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D interactions with the growth hormone locus in cellular signalling and cancer-related pathways.
    Jain L; Fadason T; Schierding W; Vickers MH; O'Sullivan JM; Perry JK
    J Mol Endocrinol; 2020 May; 64(4):209-222. PubMed ID: 32106092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Genome-Wide Pharmacogenetic Study of Growth Hormone Responsiveness.
    Dauber A; Meng Y; Audi L; Vedantam S; Weaver B; Carrascosa A; Albertsson-Wikland K; Ranke MB; Jorge AAL; Cara J; Wajnrajch MP; Lindberg A; Camacho-Hübner C; Hirschhorn JN
    J Clin Endocrinol Metab; 2020 Oct; 105(10):3203-14. PubMed ID: 32652002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH1) gene variation and the growth hormone receptor (GHR) exon 3 deletion polymorphism in a West-African population.
    Millar DS; Lewis MD; Horan M; Newsway V; Rees DA; Easter TE; Pepe G; Rickards O; Norin M; Scanlon MF; Krawczak M; Cooper DN
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):18-25. PubMed ID: 18950677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms in the locus control region and promoter of GH1 are related to serum IGF-I levels and height in patients with isolated growth hormone deficiency and healthy controls.
    de Graaff LC; Argente J; van Meurs JB; Uitterlinden AG; Hokken-Koelega AC
    Horm Res Paediatr; 2010; 73(1):25-34. PubMed ID: 20190537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: the Malmö Diet and Cancer study.
    Hallengren E; Almgren P; Engström G; Hedblad B; Persson M; Suhr J; Bergmann A; Melander O
    J Am Coll Cardiol; 2014 Oct; 64(14):1452-60. PubMed ID: 25277616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human growth hormone (GH1) gene polymorphism map in a normal-statured adult population.
    Esteban C; Audí L; Carrascosa A; Fernández-Cancio M; Pérez-Arroyo A; Ulied A; Andaluz P; Arjona R; Albisu M; Clemente M; Gussinyé M; Yeste D
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):258-68. PubMed ID: 17223997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between nocturnal growth hormone concentrations, serum IGF-I/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children.
    Mericq V; Román R; Iñiguez G; Angel B; Salazar T; Avila A; Perez-Bravo F; Cassorla F
    Horm Res; 2007; 68(3):132-8. PubMed ID: 17347571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults.
    Meyer S; Schaefer S; Stolk L; Arp P; Uitterlinden AG; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Weise A; Pfützner A; Kann PH
    Pharmacogenomics; 2009 Oct; 10(10):1599-608. PubMed ID: 19842933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
    Baş F; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Sıklar Z; Öcal G; Timirci Ö; Çetinkaya S; Darcan Ş; Gökşen Şimşek D; Bideci A; Cinaz P; Böber E; Demir K; Bereket A; Turan S; Atabek ME; Tütüncüler F; Isbir T; Bozkurt N; Kabataş Eryılmaz S; Uzunhan O; Küçükemre Aydın B; Bundak R
    Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
    Braz AF; Costalonga EF; Trarbach EB; Scalco RC; Malaquias AC; Guerra-Junior G; Antonini SR; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1808-13. PubMed ID: 24905066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth Hormone (GH) receptor C.1319 G>T polymorphism, but not exon 3 retention or deletion is associated with better first-year growth response to GH therapy in patients with GH deficiency.
    Wan L; Chen WC; Tsai Y; Kao YT; Hsieh YY; Lee CC; Tsai CH; Chen CP; Tsai FJ
    Pediatr Res; 2007 Dec; 62(6):735-40. PubMed ID: 17957148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.